Table 4. Black men and White men undergoing diagnostic procedures, by the NICE guidance risk categories for men with clinically localised disease, and clinically advanced disease (T3/T4).
|
Underwent investigation; Black/White men
|
||||
|---|---|---|---|---|
|
Underwent procedure N (%)
|
Crude estimates | Age adjusted | ||
| NICE risk category a | Black men | White men | OR (95% CI) | OR (95% CI) |
| Bone scanning (n=1068) | ||||
| Low risk | 39/64 (61) | 73/133 (55) | 1.28 (0.70, 2.35) | 1.10 (0.59, 2.07) |
| Intermediate risk | 58/72 (81) | 99/147 (67) | 2.01 (1.02, 3.59) | 1.85 (0.92, 3.73) |
| High risk | 171/183 (93) | 277/337 (82) | 3.09 (1.61, 5.90) | 1.84 (0.91, 3.69) |
| Clinically advanced | 34/39 (87) | 71/93 (76) | 2.11 (0.73, 6.04) | 1.50 (0.50, 4.53) |
| Interaction P-value | 0.29 | 0.42 | ||
| CT scanning (n=796) | ||||
| Low risk | 9/56 (16) | 25/121 (21) | 0.74 (0.32, 1.70) | 0.58 (0.24, 1.39) |
| Intermediate risk | 20/66 (30) | 22/123 (18) | 2.00 (1.00, 4.01) | 1.94 (0.94, 4.02) |
| High risk | 43/144 (30) | 57/286 (20) | 1.71 (1.08, 2.71) | 1.24 (0.76, 2.02) |
| Clinically advanced | 7/35 (20) | 17/88 (19) | 1.04 (0.39, 2.79) | 0.98 (0.36, 2.69) |
| Interaction P-value | 0.24 | 0.27 | ||
Abbreviations: CI=confidence interval; CT=computed tomography; NICE=National Institute for Health and Clinical Excellence; OR=odds ratio.
a
Low risk: PSA <10 ng ml−1 and Gleason score of ⩽6; intermediate risk: PSA between 10 and 19.99 or Gleason score of 7; high risk: PSA >20 or Gleason score of ⩾8.